New York, Dec. 27, 2022 (GLOBE NEWSWIRE) — Insilico Medication (“Insilico”), a clinical-stage end-to-end synthetic intelligence (AI)-driven drug discovery firm, right this moment introduced that the corporate’s drug discovery crew has nominated a preclinical...